Association of mineral metabolism with an increase in cellular adhesion molecules: Another link to cardiovascular risk in maintenance haemodialysis?

Nephrology Dialysis Transplantation

Volumn 21, Issue 4, 2006, Pages 999-1005

  Arici, Mustafa ^a   Kahraman, Serkan ^a   Gençtoy, Gültekin ^a   Altun, Bülent ^a   Kalyoncu, Umut ^a   Oto, Aytekin ^a   Kirazli, Şerafettin ^a   Erdem, Yunus ^a   Yasavul, Ünal ^a   Turgan, Çetin ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Adhesion molecules; Atherosclerosis; Calcium phosphate product; Carotid artery intima media thickness; Haemodialysis; Mineral metabolism

Indexed keywords

CALCIUM; CALCIUM PHOSPHATE; CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; MINERAL; PHOSPHATE; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGE DISTRIBUTION; ARTICLE; ATHEROSCLEROSIS; BONE MINERAL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY; CLINICAL STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPERCALCEMIA; HYPERPHOSPHATEMIA; INFECTION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MINERAL METABOLISM; MORBIDITY; MORTALITY; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; SEX DIFFERENCE; SOLUBILITY; STATISTICAL SIGNIFICANCE; VASCULAR DISEASE;

ATHEROSCLEROSIS; CALCIUM; CAROTID ARTERY DISEASES; CELL ADHESION; E-SELECTIN; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PHOSPHATES; RENAL DIALYSIS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 33645275451     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfi308     Document Type: Article

References (37)

1. Block GA, Port FK. Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management. Am J Kidney Dis 2000; 35: 1226-1237
2. Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic haemodialysis patients: A national study. Am J Kidney Dis 1998; 31: 607-617
3. Ganesh SK, Stack AG, Levin NW, Hulbert-Shearon TE, Port FK. Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic haemodialysis patients. J Am Soc Nephrol 2001; 12: 2131-2138
4. Sarnak MJ, Levey AS. Cardiovascular disease and chronic renal disease: A new paradigm. Am J Kidney Dis 2000; 35 [4 Suppl 1]: S117-S131
5. Cozzolino M, Brancaccio D, Gallieni M, Slatopolsky E. Pathogenesis of vascular calcification in chronic kidney disease. Kidney Int 2005; 68: 429-436
6. Goodman WG, London G, Amann K. Vascular Calcification Work Group. Vascular calcification in chronic kidney disease. Am J Kidney Dis 2004; 43: 572-579
7. Floege J, Ketteler M. Vascular calcification in patients with end-stage renal disease. Nephrol Dial Transplant 2004; 19 [Suppl 5]: V59-v66
8. London GM. Cardiovascular calcifications in uremic patients: Clinical impact on cardiovascular function. J Am Soc Nephrol 2003; 14 [9 Suppl 4]: S305-S309
9. Arici M, Walls J. End-stage renal disease, atherosclerosis, and cardiovascular mortality: Is C-reactive protein the missing link? Kidney Int 2001; 59: 407-414
10. Krieglstein CF, Granger DN. Adhesion molecules and their role in vascular disease. Am J Hypertens 2001; 14: S44-S54
11. Schmidt AM, Hori O, Chen JX et al. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. J Clin Invest 1995; 96: 1395-1403
12. Blann AD, McCollum CN. Circulating endothelial cell/leukocyte adhesion molecules in atherosclerosis. Thromb Haemost 1994; 72: 151-154
13. Blankenberg S, Rupprecht HJ, Bickel C et al. Circulating cell adhesion molecules and death in patients with coronary artery disease. Circulation 2001; 104: 1336-1342
14. National Kidney Foundation: K/DOQI™ clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003; 42 [Suppl 3]: S1-S202
15. Young EW, Akiba T, Albert JM et al. Magnitude and impact of abnormal mineral metabolism in haemodialysis patients in the dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis 2004; 44 [Suppl 2]: S34-S38
16. Aly ZA, Gonzalez EA, Martin KJ, Gellens ME. Achieving K/DOQI laboratory target values for bone and mineral metabolism: An uphill battle. Am J Nephrol 2004; 24: 422-446
17. Chertow GM, Burke SK, Raggi P for the Treat to Goal Working Group. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 2002; 62: 245-252
18. Ferramosca E, Burke S, Chasan-Taber S, Ratti C, Chertow GM, Raggi P. Potential antiatherogenic and anti-inflammatory properties of sevelamer in maintenance haemodialysis patients. Am Heart J 2005; 149: 820-825
19. Marchais SJ, Metivier F, Guerin AP, London GM. Association of hyperphosphataemia with haemodynamic disturbances in end-stage renal disease. Nephrol Dial Transplant 1999; 14: 2178-2183
20. Block GA, Klassen PS, Lazarus JM, Ofsthun NM, Lowrie EG, Chertow GM. Mineral metabolism, mortality, and morbidity in maintenance haemodialysis. J Am Soc Nephrol 2004; 15: 2208-2218
21. Rodriguez-Benot A, Martin-Malo A, Alvarez-Lara A, Rodriguez M, Aljama P. Mild hyperphosphatemia and mortality in haemodialysis patients. Am J Kidney Dis 2005; 46: 68-77
22. Kestenbaum B, Sampson JN, Rudser KD et al. Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol 2005; 16: 520-528
23. Jono S, McKee MD, Murry CE et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 2000; 87: E10-E17
24. Ishimura E, Taniwaki H, Tabata T et al Cross-sectional association of serum phosphate with carotid intima-medial thickness in haemodialysis patients. Am J Kidney Dis 2005; 45: 859-865
25. Raggi P, Boulay A, Chasan-Taber S et al Cardiac calcification in adult haemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol 2002; 39: 695-701
26. Goodman WG, Goldin J, Kuizon BD et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000; 342: 1478-1483
27. Yildiz A, Tepe S, Oflaz H et al Carotid atherosclerosis is a predictor of coronary calcification in chronic haemodialysis patients. Nephrol Dial Transplant 2004; 19: 885-891
28. Ross R. Atherosclerosis: An inflammatory disease. N Engl J Med 1999; 340: 115-126
29. Davies MJ, Gordon JL, Pigott R, Woolf N, Katz D, Kyriakopoulos A. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J Pathol 1993; 171: 223-229
30. Bro S, Moeller F, Andersen CB, Olgaard K, Nielsen LB. Increased expression of adhesion molecules in uremic atherosclerosis in apolipoprotein-E-deficient mice. J Am Soc Nephrol 2004; 15: 1495-1503
31. Rohde LE, Lee RT, Rivero J et al Circulating cell adhesion molecules are correlated with ultrasound-based assessment of carotid atherosclerosis. Arterioscler Thromb Vasc Biol 1998; 18: 1765-1770
32. Rabb H, Calderon E, Bittle PA, Ramirez G. Alterations in soluble intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in haemodialysis. Am J Kidney Dis 1996; 27: 239-243
33. Bonomini M, Reale M, Santarelli P, Stuard S, Settefrati N, Albertazzi A. Serum levels of soluble adhesion molecules in chronic renal failure and dialysis patients. Nephron 1998; 79: 399-407
34. Stenvinkel P, Lindholm B, Heimbürger M, Heimbürger O. Elevated serum levels of soluble adhesion molecules predict death in pre-dialysis patients: Association with malnutrition, inflammation, and cardiovascular disease. Nephrol Dial Transplant 2000; 15: 1624-1630
35. Papagianni A, Kalovoulos M, Kirmizis D et al. Carotid atherosclerosis is associated with inflammation and endothelial cell adhesion molecules in chronic haemodialysis patients. Nephrol Dial Transplant 2003; 18: 113-119
36. Papayianni A, Alexopoulos E, Giamalis P et al Circulating levels of ICAM-1, VCAM-1, and MCP-1 are increased in haemodialysis patients: association with inflammation, dyslipidemia, and vascular events. Nephrol Dial Transplant 2002; 17: 435-441
37. Movilli E, Feliciani A, Carnerini C et al. A high calcium-phosphate product is associated with high C-reactive protein concentration in hemodialysis patients. Nephron Clin Pract 2005; 101: C161-c177